Minnelide ameliorates Col4a5+/− mice by upregulating Col4a5 and alleviating endoplasmic reticulum stress

Minnelide demonstrates potent renoprotective effects in AS by upregulating Col4a5 expression and mitigating podocyte ER stress, positioning it as a novel therapeutic candidate.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2026-02-09
DOI
https://doi.org/10.3389/fphar.2026.1761502
Primary Topic
Renal Diseases and Glomerulopathies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Minnelide ameliorates Col4a5+/− mice by upregulating Col4a5 and alleviating endoplasmic reticulum stress

Jingjia Zhang, Baowei Ji, Ye Yin, Jun-chao Liu et al.
Frontiers in Pharmacology
Renal Diseases and Glomerulopathies
article

Minnelide ameliorates Col4a5+/− mice by upregulating Col4a5 and alleviating endoplasmic reticulum stress

Jingjia Zhang, Baowei Ji, Ye Yin, Jun-chao Liu, Fu-jie Wen, Hong Xu, Xue Wang, Qian Shen, Jian Yu
article en

Abstract

Minnelide demonstrates potent renoprotective effects in AS by upregulating Col4a5 expression and mitigating podocyte ER stress, positioning it as a novel therapeutic candidate.

Frontiers in PharmacologyVol. 17
Kidney Research UK (GB), Institut thématique Génétique, génomique et bioinformatique (FR), Children's Hospital of Fudan University (CN), Hefei First People's Hospital (CN)
National Natural Science Foundation of China
Openalex Percentile: Top 66%
Renal Diseases and Glomerulopathies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.